Skip to main content
Log in

Monoamine metabolites in cerebrospinal fluid during treatment of hypertension with prazosin

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Six hypertensive patients were treated with prazosin up to a final dose of 3–4.5 mg/day. There was a significant reduction of blood pressure. The cerebrospinal fluid (CSF) concentrations of the major metabolites of noradrenaline, dopamine and serotonin were unchanged. This indicates that the antihypertensive effect is not mediated via central monoaminergic neurons as suggested by animal studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Andén NE, Gomes C, Persson B, Trolin G (1978) R 28935 and Prazosin: Effects on central and peripheral alpha-adrenoreceptor activity and on blood pressure. Naunyn Schmiedebergs Arch Pharmacol 302: 299–306

    Google Scholar 

  • Bertilsson L, Atkinson AJ, Althaus JR, Härfast Å, Lindgren JE, Holmstedt B (1972) Quantitative determination of 5-hydroxyindole-3-acetic acid in cerebrospinal fluid by gas chromatography-mass-spectrometry. Anal Chem 44: 1434–38

    Google Scholar 

  • Bertilsson L (1973) Quantitative determination of 4-hydroxy-3-methoxyphenyl glycol and its conjugates in cerebrospinal fluid by mass fragmentography. J. Chromatogr 87: 147–153

    Google Scholar 

  • Bertilsson L, Haglund K, Östman J, Rawlins MD, Ringberger V-A, Sjöqvist F (1977) Monoamine metabolites in cerebrospinal fluid during treatment with clonidine or alprenolol. Eur J Clin Pharmacol 11: 125–128

    Google Scholar 

  • Day MD, Roach AG (1974) Central adrenoceptors and the control of arterial blood pressure. Clin Exp Pharmacol Physiol 1: 347–60

    Google Scholar 

  • Fuller RW, Snoddy HD, Perry KW (1977) Effect of prazosin on norepinephrine turnover in rat brain. Fed Proc 36: 407

    Google Scholar 

  • Kincaid-Smith P, Hua ASP, Myers JB, Macdonald I, Fang P (1976) Prazosin and hydralazin in the treatment of hypertension. Clin Sci Mol Med 51: 617–19

    Google Scholar 

  • Lund-Johansen P (1974) Hemodynamic changes at rest and during exercise in longterm prazosin therapy of essential hypertension. In: Rawlins MD, Geyer G, Bleifeld W (eds) Prazosin. Evaluation of a new anti-hypertensive agent. Excerpta Medica, Geneva, pp 43–45

    Google Scholar 

  • Offerhaus L, van Zwieten PA (1974) Comparative studies on central factors contributing to the hypotensive action of propranolol, alprenolol and their enantiomers. Cardiovasc Res 8: 488–95

    Google Scholar 

  • Rosenthal J, Jaeger H, Arlart I (1978) Effects of prazosin on blood pressure and plasma renin activity in man. Clin Sci Mol Med 55: 337–339

    Google Scholar 

  • Sjöquist B, Änggård E (1972) Gas chromatographic determination of homovanillic acid in human cerebrospinal fluid by electron capture detection and by mass fragmentography with a deuterated internal standard. Anal Chem 44: 2297–2301

    Google Scholar 

  • Van Zwieten PA (1973) The central action of antihypertensive drugs, mediated via central α-receptor. J Pharm Pharmacol 25: 89–95

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seideman, P., Bertilsson, L., Haglund, K. et al. Monoamine metabolites in cerebrospinal fluid during treatment of hypertension with prazosin. Eur J Clin Pharmacol 18, 399–401 (1980). https://doi.org/10.1007/BF00636792

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00636792

Key words

Navigation